Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC in Primary Ovarian Cancer
NCT03321188Phase 2Unknown
- Start
- Dec 2017
- Primary completion
- Dec 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC). Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT03321188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321188.